Home Cart 0 Sign in  
X

[ CAS No. 10288-72-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 10288-72-9
Chemical Structure| 10288-72-9
Chemical Structure| 10288-72-9
Structure of 10288-72-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 10288-72-9 ]

Related Doc. of [ 10288-72-9 ]

Alternatived Products of [ 10288-72-9 ]

Product Details of [ 10288-72-9 ]

CAS No. :10288-72-9 MDL No. :MFCD06656571
Formula : C8H8O3 Boiling Point : -
Linear Structure Formula :- InChI Key :DBPZCGJRCAALLW-UHFFFAOYSA-N
M.W : 152.15 Pubchem ID :9115273
Synonyms :

Calculated chemistry of [ 10288-72-9 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.25
Num. rotatable bonds : 0
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 39.34
TPSA : 38.69 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.42 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.69
Log Po/w (XLOGP3) : 1.14
Log Po/w (WLOGP) : 1.16
Log Po/w (MLOGP) : 0.47
Log Po/w (SILICOS-IT) : 1.7
Consensus Log Po/w : 1.23

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.91
Solubility : 1.89 mg/ml ; 0.0124 mol/l
Class : Very soluble
Log S (Ali) : -1.55
Solubility : 4.32 mg/ml ; 0.0284 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.84
Solubility : 2.21 mg/ml ; 0.0146 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.32

Safety of [ 10288-72-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 10288-72-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 10288-72-9 ]
  • Downstream synthetic route of [ 10288-72-9 ]

[ 10288-72-9 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 29668-44-8 ]
  • [ 10288-72-9 ]
YieldReaction ConditionsOperation in experiment
94% With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 50℃; for 16 h; To a solution of 2,3-dihydro-benzo[1,4]dioxin-6-carboxaldehyde (30.0 g, 183 mmol) in 500 ml CH2Cl2 was added mCPBA (37.85 g, 219 mmol).
The suspension was heated to 50° C.
After 16 h saturated NaHCO3 was added and the mixture was extracted with CH2Cl2 The combined organics were concentrated in vacuo and taken up in MeOH and 200 ml 4M NaOH was added.
After 2 h the mixture was acidified with 4M HCl and extracted with ethyl acetate.
The combined organics were washed with saturated NaHCO3, washed with brine, concentrated in vacuo, and taken up in CH2Cl2.
The solution was filtered to remove the precipitate.
The resulting solution was stirred with saturated NaHCO3 for 1 h, separated, dried over MgSO4, filtered and concentrated in vacuo to give 2,3-dihydro-benzo[1,4]dioxin-6-ol (26.92 g, 94percent).
94%
Stage #1: With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 50℃; for 16 h;
Stage #2: With sodium hydroxide In methanol; water for 2 h;
To a solution of 2,3-dihydro-benzo[1,4]dioxin-6-carboxaldehyde (30.0 g, 183 mmol) in 500 ml CH2Cl2 was added mCPBA (37.85 g, 219 mmol).
The suspension was heated to 50° C.
After 16 h saturated NaHCO3 was added and the mixture was extracted with CH2Cl2.
The combined organics were concentrated in vacuo and taken up in MeOH and 200 ml 4M NaOH was added.
After 2 h the mixture was acidified with 4M HCl and extracted with ethyl acetate.
The combined organics were washed with saturated NaHCO3, washed with brine, concentrated in vacuo, and taken up in CH2Cl2.
The solution was filtered to remove the precipitate.
The resulting solution was stirred with saturated NaHCO3 for 1 h, separated, dried over MgSO4, filtered and concentrated in vacuo to give 2,3-dihydro-benzo[1,4]dioxin-6-ol (26.92 g, 94percent).
92% for 0.0833333 h; Procedure: 2,3-dihydrobenzo[b][1 ,4]dioxine-6-carbaldehyde (2 g, 12.2 mmol, 1 eq.) was placed in a mortar, mCPBA (4.5 g, 18.3 mmol, 1.5 eq.) was added and the solids were mixed with a pestle. The resulting paste left at room temperature for 5 min and then diluted with NaOH (10percent in H20). The solution was washed with Et20, adjusted to pH 7 with HCI (2 m) and extracted with DCM. After the combined organic layers were dried over Na2S04, the solvent was evaporated and the product was purified via flash chromatography (Si02, nHex/EtOAc/AcoH 79/20/1 ).Yield: 1.7 g, 1 1.2 mmol, 92percent (off white solid).TLC: PE/EtOAc/AcOH 74/25/11H NMR (CDCI3,200 MHz, ppm): δ 6.72 (dd, J = 8.6, 0.4 Hz, 1 H), 6.40 (dd, J = 2.9, 0.4 Hz, 1 H), 6.33 (dd, J = 8.6, 2.9 Hz, 1 H), 4.32 - 4.14 (m, 4H), 4.00 (s, 1 H).13C NMR (CDCI3, 50 Hz, ppm): δ 150.1 , 144.0, 137.7, 1 17.7, 108.5, 104.4, 64.7, 64.2.
78% With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 40℃; for 12 h; Inert atmosphere To a solution of 21 (5 g, 30.48 mmol) in DCM (80 mL) was added mCPBA (9 g, 45.72 mmol) under N2 atmosphere, and the reaction mixture was stirred for 12 h at 40. The resulting reaction mixture was quenched by saturated NaHCO3 aqueous solution (50 ml) and extracted with CH2Cl2 (50 mL × 3). The combined organic layer was dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The residue was dissolved in MeOH (20 ml) and added NaOH (1.46 g, 36.58 mmol). After the mixture was stirred for 15 min, the reaction mixture was adjusted to PH 6-7 with HCl (4 N aqueous solution) and extracted with methyl tert-butyl ether (50 mL × 3). The combined organic layer was washed with saturated aqueous NaHCO3 solution (100 ml) and brine (100 mL), dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by flash column chromatography eluting with ethyl acetate/petroleum ether (1:3-1:2) to afford the intermediate 22 (3.6 g, 78percent yield) as a yellow solid.1H NMR (400 MHz, DMSO-d6) δ 8.92 (s, 1H), 6.62 (d, J = 8.4 Hz, 1H), 6.25-6.21 (m, 2H), 4.19 – 4.14 (m, 2H), 4.14 – 4.08 (m, 2H). 13C NMR (101 MHz, DMSO-d6) δ 151.55 (s), 143.50 (s), 136.09 (s), 117.08 (s), 107.93 (s), 103.59 (s), 64.23 (s), 63.67 (s).
63%
Stage #1: With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 50℃; for 48 h;
Stage #2: at 20℃; for 2 h;
Stage #3: With hydrogenchloride; water In methanol
EXAMPLE 37 Scheme 37a[00319] Synthesis of N-(6-(6-(2,3-dihydrobenzo[λ] [1,4]dioxin-6-yloxy)pyrimidin-4- ylamino)pyridin-2-yl)acrylamide (1-95)Step lTo a stirred solution of 2,3-dmydrobenzo[6][1,4]dioxine-6-carbaldehyde (1 g, 6.09 mmol) in CH2Cl2 (16 mL) was added /w-CPBA (4.204 g, 24.36 mmol). The suspension was heated at 50 °C for 2 days, was cooled to it, was quenched with saturated NaHCO3 soln. and was extracted with CH2Cl2 (3x10 mL). The combined extract was concentrated under reduced pressure, and then was dissolved in MeOH containing NaOH. The solution was stirred at rt for 2 h, was acidified with HCl and was extracted with ethyl acetate (3x10 mL). The combined extract was washed with saturated NaHCO3 solution and brine, was dried over anhydrous Na2SO4, was filtered and was concentrated under reduced pressure. The residue was dissolved in CH2Cl2 and was filtered. The DCM solution was dried over anhydrous Na2SO4, was filtered and was concentrated under reduced pressure to give 2,3-dihydrobenzo[Z>][1,4]dioxin-6-ol (0.591 g, 63percent) as a reddish brown oily liquid.

Reference: [1] Patent: US2005/209260, 2005, A1, . Location in patent: Page/Page column 114
[2] Patent: US2007/49609, 2007, A1, . Location in patent: Page/Page column 102
[3] Patent: WO2018/134254, 2018, A1, . Location in patent: Page/Page column 68
[4] Chemistry and Biodiversity, 2010, vol. 7, # 4, p. 887 - 897
[5] Bioorganic and Medicinal Chemistry, 2002, vol. 10, # 6, p. 2051 - 2066
[6] European Journal of Medicinal Chemistry, 2018, vol. 157, p. 380 - 396
[7] Patent: WO2009/51822, 2009, A1, . Location in patent: Page/Page column 150
[8] Bioscience, Biotechnology, and Biochemistry, 1992, vol. 56, # 2.3.4., p. 630 - 635
[9] Tetrahedron, 2004, vol. 60, # 40, p. 8899 - 8912
[10] Patent: US2011/87027, 2011, A1, . Location in patent: Page/Page column 11-12
[11] Patent: WO2012/49555, 2012, A1, . Location in patent: Page/Page column 56-57
  • 2
  • [ 22013-33-8 ]
  • [ 10288-72-9 ]
Reference: [1] European Journal of Medicinal Chemistry, 1989, vol. 24, p. 619 - 622
[2] Journal of the American Oil Chemists' Society, 1956, vol. 33, p. 414
[3] Journal of the Chemical Society, 1957, p. 3445
[4] European Journal of Medicinal Chemistry, 1990, vol. 25, # 1, p. 45 - 51
[5] Tetrahedron Letters, 1988, vol. 29, # 22, p. 2665 - 2666
[6] Patent: US5736543, 1998, A,
  • 3
  • [ 7159-14-0 ]
  • [ 10288-72-9 ]
Reference: [1] Tetrahedron, 1995, vol. 51, # 11, p. 3197 - 3204
[2] Journal of Medicinal Chemistry, 2005, vol. 48, # 1, p. 71 - 90
[3] Patent: US2005/176726, 2005, A1, . Location in patent: Page/Page column 20
[4] Patent: US6313160, 2001, B1,
  • 4
  • [ 782471-87-8 ]
  • [ 10288-72-9 ]
Reference: [1] Tetrahedron, 2004, vol. 60, # 40, p. 8899 - 8912
  • 5
  • [ 57744-67-9 ]
  • [ 10288-72-9 ]
Reference: [1] Journal of Organic Chemistry, 2013, vol. 78, # 11, p. 5804 - 5809
  • 6
  • [ 107-21-1 ]
  • [ 106-51-4 ]
  • [ 10288-72-9 ]
Reference: [1] Tetrahedron Letters, 2014, vol. 55, # 1, p. 86 - 89
  • 7
  • [ 139-85-5 ]
  • [ 10288-72-9 ]
Reference: [1] Patent: US2011/87027, 2011, A1,
[2] Patent: WO2012/49555, 2012, A1,
[3] European Journal of Medicinal Chemistry, 2018, vol. 157, p. 380 - 396
  • 8
  • [ 78541-20-5 ]
  • [ 10288-72-9 ]
Reference: [1] Polish Journal of Chemistry, 1980, vol. 54, # 11/12, p. 2239 - 2242
  • 9
  • [ 493-09-4 ]
  • [ 10288-72-9 ]
Reference: [1] Polish Journal of Chemistry, 1980, vol. 54, # 11/12, p. 2239 - 2242
  • 10
  • [ 120-80-9 ]
  • [ 10288-72-9 ]
Reference: [1] Polish Journal of Chemistry, 1980, vol. 54, # 11/12, p. 2239 - 2242
  • 11
  • [ 52287-51-1 ]
  • [ 10288-72-9 ]
Reference: [1] Polish Journal of Chemistry, 1980, vol. 54, # 11/12, p. 2239 - 2242
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 10288-72-9 ]

Alcohols

Chemical Structure| 3250-73-5

[ 3250-73-5 ]

2-(2-Ethoxyphenoxy)ethanol

Similarity: 0.93

Chemical Structure| 4792-78-3

[ 4792-78-3 ]

2-(2-Hydroxyethoxy)phenol

Similarity: 0.93

Chemical Structure| 10234-40-9

[ 10234-40-9 ]

2,2'-(1,2-Phenylenebis(oxy))diethanol

Similarity: 0.93

Chemical Structure| 102-40-9

[ 102-40-9 ]

2,2'-(1,3-Phenylenebis(oxy))diethanol

Similarity: 0.85

Chemical Structure| 49650-88-6

[ 49650-88-6 ]

3-(2-Hydroxyethoxy)phenol

Similarity: 0.85

Related Parent Nucleus of
[ 10288-72-9 ]

Benzodioxans

Chemical Structure| 493-09-4

[ 493-09-4 ]

2,3-Dihydrobenzo[b][1,4]dioxine

Similarity: 0.96

Chemical Structure| 1710-62-9

[ 1710-62-9 ]

5-(2-Bromoethoxy)-2,3-dihydrobenzo[b][1,4]dioxine

Similarity: 0.84

Chemical Structure| 10288-82-1

[ 10288-82-1 ]

2-((2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)oxy)acetic acid

Similarity: 0.79

Chemical Structure| 3663-82-9

[ 3663-82-9 ]

(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methanol

Similarity: 0.79

Chemical Structure| 98572-00-0

[ 98572-00-0 ]

(S)-(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methanol

Similarity: 0.79